How do hormonal changes in pregnancy contribute to the development of obstructive sleep apnea (OSA) in at-risk mothers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormonal Changes in Pregnancy Contributing to Obstructive Sleep Apnea

Pregnancy-related hormonal changes significantly increase the risk of obstructive sleep apnea (OSA) in at-risk mothers through multiple physiological mechanisms that affect upper airway patency and respiratory control. 1

Key Hormonal Mechanisms

Estrogen and Progesterone Effects

  • Estrogen:

    • Causes mucosal edema and hyperemia in the upper respiratory tract
    • Increases mucus production in the respiratory system
    • Contributes to nasal congestion and upper airway narrowing
  • Progesterone:

    • Initially protective through respiratory stimulation
    • However, rising levels can paradoxically worsen OSA by:
      • Promoting fluid retention
      • Contributing to weight gain
      • Affecting upper airway muscle tone during sleep

Weight Gain and Fat Distribution

  • Pregnancy-related weight gain (especially in already obese women) significantly increases OSA risk
  • Hormonal changes direct fat deposition to neck and pharyngeal areas
  • Each 10% increase in body weight increases OSA risk by approximately 6-fold 2

Fluid Retention and Edema

  • Increased estrogen causes sodium and fluid retention
  • Fluid shifts to upper body during recumbent position at night
  • Results in pharyngeal edema and narrowing of upper airway

Trimester-Specific Changes

First Trimester

  • Initial hormonal changes begin affecting upper airway tissues
  • Relatively fewer OSA symptoms compared to later trimesters

Second and Third Trimesters

  • Dramatic increase in OSA prevalence and severity
  • Peak hormonal effects combined with maximal weight gain
  • Upward displacement of diaphragm by enlarging uterus further compromises respiratory function
  • Studies show 26% of women in third trimester have diagnosable OSA 3

Specific Mechanisms of Airway Obstruction

  1. Reduced Pharyngeal Lumen Size:

    • Hormonal edema of mucous membranes
    • Increased neck circumference from weight gain
  2. Altered Respiratory Control:

    • Progesterone initially increases respiratory drive but can lead to respiratory instability
    • Increased sensitivity to carbon dioxide levels
  3. Reduced Functional Residual Capacity:

    • Upward displacement of diaphragm
    • Decreased oxygen reserves during apneic episodes

Risk Factors That Interact With Hormonal Changes

  • Pre-pregnancy obesity (BMI >30)
  • Excessive gestational weight gain
  • Pre-existing anatomical narrowing of upper airway
  • History of snoring before pregnancy
  • Advanced maternal age
  • Multiple gestation

Clinical Implications

  • OSA in pregnancy is associated with increased risk of:

    • Gestational hypertension and preeclampsia
    • Gestational diabetes
    • Intrauterine growth restriction
    • Preterm birth 4
  • Early recognition and treatment with CPAP has been shown to:

    • Lower diastolic blood pressure by approximately 2.2 mmHg
    • Reduce preeclampsia rates (13.1% vs 22.3% in untreated) 4

Screening and Diagnosis

  • High clinical suspicion needed for at-risk mothers (obese, chronic hypertension, history of OSA)
  • Type III portable monitoring devices can be effective for screening with an AHI cutoff of 2.25 events/hour showing good sensitivity (85.7%) 3
  • Polysomnography remains the gold standard for diagnosis

Management Considerations

  • CPAP therapy is the most effective treatment
  • Position therapy (sleeping on side) may provide partial relief
  • Weight management before and during pregnancy is crucial for prevention
  • Monthly monitoring of symptoms throughout pregnancy is recommended

Understanding these hormonal mechanisms is essential for early identification and management of OSA in pregnant women, particularly those with pre-existing risk factors.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.